These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6153938)

  • 21. [Tumor chemotherapy: synthesis of N-hydroxyethyl-isoquinoline-3-carboxylic lactone derivatives].
    Yan XM; Weng ZY
    Yao Xue Xue Bao; 1985 Apr; 20(4):312-5. PubMed ID: 4072705
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis and anticancer activities of 6-amino amonafide derivatives.
    Norton JT; Witschi MA; Luong L; Kawamura A; Ghosh S; Stack MS; Sim E; Avram MJ; Appella DH; Huang S
    Anticancer Drugs; 2008 Jan; 19(1):23-36. PubMed ID: 18043127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor activity of Nitronaphthal-NU, a novel mixed-function agent.
    Samanta S; Pain A; Dutta S; Saxena AK; Shanmugavel M; Pandita RM; Qazi GN; Sanyal U
    J Exp Ther Oncol; 2005; 5(1):15-22. PubMed ID: 16416597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Synthesis and toxic properties of organoarsenic compounds].
    Selivanova AS; Molodykh ZhV; Gamaiurova VS; Chernokal'skiĭ BD; Il'ina SV
    Dokl Akad Nauk SSSR; 1974 Sep; 218(2):493-6. PubMed ID: 4434832
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and evaluation of substituted naphthalimide nitrogen mustards as rationally designed anticancer compounds.
    Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Quazi GN; Sanyal U
    Acta Pol Pharm; 2003; 60(4):285-91. PubMed ID: 14714857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amino-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H- dibenz[de,h]isoquinoline-1,3-diones. Synthesis, antitumor activity, and quantitative structure--activity relationship.
    Sami SM; Dorr RT; Sólyom AM; Alberts DS; Remers WA
    J Med Chem; 1995 Mar; 38(6):983-93. PubMed ID: 7699715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible antineoplastic agents I.
    De AU; Pal D
    J Pharm Sci; 1975 Feb; 64(2):262-6. PubMed ID: 1127582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of various new cytostatic agents on DNA reduplication and proliferation kinetics in the Ehrlich-Lettre ascites tumor model].
    Andreeff M
    Verh Dtsch Ges Inn Med; 1974; 80():1678-80. PubMed ID: 4454511
    [No Abstract]   [Full Text] [Related]  

  • 29. Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642).
    Costanza ME; Berry D; Henderson IC; Ratain MJ; Wu K; Shapiro C; Duggan D; Kalra J; Berkowitz I; Lyss AP
    Clin Cancer Res; 1995 Jul; 1(7):699-704. PubMed ID: 9816035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacology of 1,6-Dibromo-1,6-dideoxy-dulcitol and its Cytostatic effect on transplantable tumours.
    Kellner B; Németh L; Sugár J; Gáti E; Pályi I; Döbrössy L
    Arzneimittelforschung; 1967 Aug; 17(8):1037-43. PubMed ID: 5244384
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapeutic activity of pretazettine on Ehrlich ascites carcinoma: adjuvant effect on standard drugs in ABC regimen.
    Furusawa E; Lum MK; Furusawa S
    Chemotherapy; 1981; 27(4):277-86. PubMed ID: 7249790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analogues of amonafide and azonafide with novel ring systems.
    Sami SM; Dorr RT; Alberts DS; Sólyom AM; Remers WA
    J Med Chem; 2000 Aug; 43(16):3067-73. PubMed ID: 10956214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activity of 1-nitro-9-aminoacridines including nitracrine against some ascitic experimental tumors.
    Mazerska Z; Lukowicz J; Konopa J
    Arzneimittelforschung; 1990 Apr; 40(4):472-7. PubMed ID: 2357249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of tetraacetyl-bis-dehydroascorbic acid, a derivative of ascorbic acid, on Ehrlich cells and HeLa cells (human carcinoma cells).
    Yagishita K; Takahashi N; Yamamoto H; Jinnouchi H; Hiyoshi S
    J Nutr Sci Vitaminol (Tokyo); 1976; 22(6):419-27. PubMed ID: 1022854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the cytotoxic mechanisms mediated by the broad-spectrum antitumor alkaloid acronycine and selected semisynthetic derivatives.
    Shieh HL; Pezzuto JM; Cordell GA
    Chem Biol Interact; 1992 Jan; 81(1-2):35-55. PubMed ID: 1730147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of Amonafide in dogs.
    Lu K; McLean MA; Vestal ML; Newman RA
    Cancer Chemother Pharmacol; 1988; 21(2):134-8. PubMed ID: 3349561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, chemical characterization and biological evaluation of new platinum (II)-sulfonamide complexes.
    Craciunescu DG; Scarcia V; Furlani A; Parrondo Iglesias E; Ravalico L; Doadrio A
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):183-7. PubMed ID: 2334458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of rebeccamycin analogues modified at the imide moiety.
    Animati F; Berettoni M; Bigioni M; Binaschi M; Cipollone A; Irrissuto C; Nardelli F; Olivieri L
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5013-7. PubMed ID: 22749423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amonafide in metastatic colorectal carcinoma.
    Scheithauer W; Kornek G; Haider K; Depisch D
    Eur J Cancer; 1990; 26(8):923-4. PubMed ID: 2145944
    [No Abstract]   [Full Text] [Related]  

  • 40. Antineoplastic activity of tetrakis-mu-(trimethylamine-boranecarboxylato)-bis (trimethylamine-carboxyborane)dicopper (II) in Ehrlich ascites carcinoma.
    Hall IH; Spielvogel BF; McPhail AT
    J Pharm Sci; 1984 Feb; 73(2):222-5. PubMed ID: 6707888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.